Alzheimer, MCI and control samples from AddneuroMed Cohort (batch 1)
Alzheimer case-control samples originate from the EU funded AddNeuroMed Cohort, which is a large cross-European AD biomarker study relying on human blood as the source of RNA.
Provenance — who produced it, who reused it
Linked to 53 papers in the literature. Roles are inferred factual signals (who deposited the data vs who reused it), with counts — never a judgement about any author.
- A novel multi-tissue RNA diagnostic of healthy ageing relates to... 2015 · 248 cites
- Prediction of Alzheimer’s disease using blood gene expression da... 2020 · 148 cites
- Gene co-expression in the interactome: moving from correlation t... 2021 · 92 cites
- Identification of diagnostic genes for both Alzheimer’s disease... 2022 · 79 cites
- Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer’... 2017 · 77 cites
48 further papers cite this accession but reuse could not be confirmed.
Deep data QC
metadata only · no data-level QC for this typeStandardized, field-standard QC computed by touching the data — every metric states how it was obtained
No quantitative QC rubric exists for this data type yet, so it is deliberately left unscored — this is an honest "not applicable", not a poor rating.
measured = computed from the data · extrapolated/reported = derived or from the repository · dq-1.0 · provisional — verify independently